ANZ: It's different this time
With all the talk about a property bubble, Nathan Bell compares ANZ circa 1992 with now to see if it's better prepared for a recession.
M2 finds life in Dodo
M2 might not have the glamour of the other telcos but, as Jason Prowd explains, that’s exactly what makes it a compelling investment.
TPG vs iiNet: Battle of the ISPs
These two ISPs have grown into fully-fledged telcos creating great wealth for shareholders, but can they hold their own in a more competitive landscape?
Leighton is no lay down
Recent allegations have rocked Leighton Holdings, but its value to shareholders rests on its potential in coming years, explains Greg Hoffman.
OzForex on the money
A competitive industry, private equity sellers and a high price aren't a good look, but we're backing this payment specialist anyway.
Duet changes its tune
Now holding three high quality assets and with internalised management, Duet is more attractive than before but not quite cheap enough.
Put Vision on your watch list
The country's largest owner of laser eye clinics offers plenty of turnaround potential, but the doctors hold most of the cards.
Ideas Lab: Perilya saved from peril
With a takeover likely to happen, this zinc and lead miner offers a slim window for a small gain. Gaurav Sodhi presents Perilya to the Ideas Lab.
News Corp: Result 2013
There were some swings and roundabouts in News Corp's full-year result, but the overall performance was pleasing.
F&P Healthcare: Breathing easy
Having just released the best range of masks in the company’s history, Nathan Bell explains why this might not be the time to sell.
Storm brews for Spark Infrastructure
The regulatory regime that governs returns is changing and with it our investment case. Gaurav Sodhi explains the changes to come.
Echo is worth a shout
Fears about the impact of Crown's new casino in Sydney have created an opportunity in the owner of The Star, explains Jason Prowd.
Three stocks to gain from more M&A
Corporate activity could be about to increase, but there are safer ways to benefit than trying to pick the next acquisition target.
Call 1300 880 160
Start a chat
Schedule a call
